Product logins

Find logins to all Clarivate products below.


Dermatitis/Eczema – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of dermatitis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of dermatitis for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the mature markets and Europe, and 10 years for the other countries we cover.

All forecast data are available on Clarivate’s Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology’s dermatitis forecast answers the following questions:

  • How will changes in the levels of exposure to known risk or protective factors affect the number of people living with dermatitis?
  • In developing countries, what impact will economic growth and development have on the number of people living with dermatitis?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of dermatitis over the forecast period?

Clarivate Epidemiology provides at least 10 years of forecast data for the following dermatitis subpopulations:

  • Total 12-month prevalent cases.

Note: Coverage may vary by country.

Related Market Assessment Reports

Report
Inflammatory Myositis – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of inflammatory myositis (IM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States,…
Report
Genitourinary Syndrome of Menopause – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of GSM comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy,…
Report
Diabetic Macular Edema – Epidemiology – Epidemiology – Diabetic Macular Edema – Mature Markets
Clarivate Epidemiology’s coverage of diabetic macular edema comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France…
Report
Diabetic Macular Edema – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of diabetic macular edema (DME) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the total and diagnosed…
Report
Diabetic Macular Edema – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key diabetic macular edema patient populations, covering 171 countries…